13F-HR: Axon Enterprise, Inc. Discloses $174.87 Million Investment in Cellebrite DI Ltd.

Axon Enterprise, Inc. reports holding $174.87 million in Cellebrite DI Ltd. as of March 31, 2025.

Summary

• Axon Enterprise, Inc. filed a Form 13F report for the quarter ended March 31, 2025.
• The report indicates that Axon Enterprise holds Ordinary Shares of Cellebrite DI Ltd.
• The total value of these holdings is reported as $174,870,000.
• Axon Enterprise holds 9,000,000 shares of Cellebrite DI Ltd.
• The filing indicates sole voting authority over these shares.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing, indicating a significant investment. The sentiment is neutral, reflecting the factual nature of the report.

Positives

• The filing indicates a significant investment by Axon Enterprise in Cellebrite DI Ltd.

Industry Context

Axon's investment in Cellebrite, a company specializing in digital intelligence solutions, suggests a strategic alignment or potential synergy between the two companies, possibly related to law enforcement technology and data analysis.

Comparison to Industry Standards

• Without additional context, it's difficult to compare this investment to industry standards.
• Further analysis would be required to determine if this investment is typical for companies in the law enforcement technology sector.
• Comparisons could be made to similar investments by companies like Motorola Solutions or other players in the public safety technology space.

Stakeholder Impact

• The investment could positively impact Cellebrite DI Ltd. shareholders.
• The investment could signal a closer relationship between Axon and Cellebrite, potentially impacting their respective customers and suppliers.

Key Dates

Keywords

Form 13F, Cellebrite DI Ltd, Axon Enterprise, Investment, Holdings, Shares